Narrative Review of the COVID-19 Pandemic's First Two Years in Italy.
COVID-19
Italy
distancing
pandemics
policy
vaccines
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
22 11 2022
22 11 2022
Historique:
received:
20
10
2022
revised:
17
11
2022
accepted:
17
11
2022
entrez:
11
12
2022
pubmed:
12
12
2022
medline:
15
12
2022
Statut:
epublish
Résumé
Italy was the first country in the western world to be affected by the COVID-19 pandemic, arguably among the worst-affected ones, counting 12 million cases and 150 thousand deaths two years since the first case. Facing new challenges, Italy has enacted different strategies and policies to limit the spread of the SARS-CoV-2 virus and treat those affected by COVID-19. This narrative review provided an overview of factors, measures, and actions that shaped Italy's first two years of the COVID-19 pandemic by investigating epidemiological data and using a mixed-method approach. This narrative review aimed to summarize the most relevant aspects and measures and analyze available data to provide policymakers and healthcare providers with the instruments to learn from this pandemic and improve their preparedness for future pandemic events. The first two years of the pandemic differ in that, during the first year, significant necessary changes to the way health systems were organized were implemented, increasing healthcare spending and adopting social and physical distancing measures that were stricter than the ones adopted in the second year. However, as the pandemic progressed, increased knowledge of the virus and related variants, as well as the introduction of highly effective vaccines, which were not equally available to the whole population, resulted in a stratification of COVID-19 infections and deaths based on factors such as age, vaccination status, and individual susceptibility to the virus.
Identifiants
pubmed: 36497543
pii: ijerph192315443
doi: 10.3390/ijerph192315443
pmc: PMC9736498
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Environ Res. 2021 Jun;197:111097
pubmed: 33811866
Turk J Med Sci. 2020 Apr 17;50(SI-1):515-519
pubmed: 32299204
Healthcare (Basel). 2022 May 11;10(5):
pubmed: 35628024
Vaccines (Basel). 2022 Sep 06;10(9):
pubmed: 36146561
Int J Environ Res Public Health. 2022 Jan 19;19(3):
pubmed: 35162115
Environ Res. 2021 Feb;193:110476
pubmed: 33221311
Influenza Other Respir Viruses. 2021 May;15(3):407-412
pubmed: 33128444
Sci Rep. 2021 Jan 28;11(1):2547
pubmed: 33510197
Nature. 2022 Jan;601(7893):312-315
pubmed: 35042997
Inflammopharmacology. 2021 Oct;29(5):1357-1360
pubmed: 34279767
FEBS J. 2020 Sep;287(17):3633-3650
pubmed: 32446285
Risk Manag Healthc Policy. 2021 Sep 13;14:3775-3782
pubmed: 34548826
Clin Case Rep. 2021 May 06;9(6):e04154
pubmed: 34178331
Viruses. 2021 Dec 30;14(1):
pubmed: 35062265
Lancet. 2020 Apr 11;395(10231):1225-1228
pubmed: 32178769
Pharmacol Res. 2020 Nov;161:105160
pubmed: 32810626
Int J Environ Res Public Health. 2022 Mar 03;19(5):
pubmed: 35270662
Int J Environ Res Public Health. 2021 Apr 29;18(9):
pubmed: 33947087
Infect Dis Model. 2020;5:588-597
pubmed: 32844134
Int J Environ Res Public Health. 2021 May 09;18(9):
pubmed: 34065117
Recenti Prog Med. 2020 Dec;111(12):788-789
pubmed: 33362178
JAMA Intern Med. 2020 Jul 1;180(7):927-928
pubmed: 32259190
G Ital Med Lav Ergon. 2021 Jun;43(2):93-98
pubmed: 34370918
Sci Total Environ. 2021 Jan 1;750:141711
pubmed: 32835962
Science. 2021 Feb 26;371(6532):916-921
pubmed: 33479118
Pathog Glob Health. 2021 Jun;115(4):211-212
pubmed: 33629933
Expert Rev Respir Med. 2021 Dec;15(12):1619-1625
pubmed: 34311634
Clin Drug Investig. 2022 Mar;42(3):237-242
pubmed: 35218000
PLoS One. 2020 Nov 12;15(11):e0242305
pubmed: 33180880
BMJ. 2021 Nov 17;375:e068302
pubmed: 34789505
J Sports Econom. 2022 Jun;23(5):503-523
pubmed: 35663345
Expert Rev Vaccines. 2022 Apr;21(4):423-425
pubmed: 34962214
Clin Infect Dis. 2021 May 4;72(9):1493-1496
pubmed: 32584967
JACC Case Rep. 2020 Jul 15;2(9):1414-1418
pubmed: 32835287
Results Phys. 2021 Dec;31:104895
pubmed: 34722137
Acta Diabetol. 2021 Jul;58(7):919-927
pubmed: 33740123
Emerg Infect Dis. 2020 Oct;26(10):2465-2468
pubmed: 32673193
J Med Virol. 2020 May;92(5):518-521
pubmed: 32022275
N Engl J Med. 2020 Nov 12;383(20):1986-1988
pubmed: 32663910
Acta Biomed. 2020 Mar 19;91(1):157-160
pubmed: 32191675
Biochem Soc Trans. 2020 Oct 30;48(5):2307-2316
pubmed: 33084885
Int J Environ Res Public Health. 2022 Jun 20;19(12):
pubmed: 35742778
Toxicol Ind Health. 2020 Sep;36(9):711-717
pubmed: 33063649
Int J Environ Res Public Health. 2020 Nov 27;17(23):
pubmed: 33261208
Lancet. 2021 Mar 27;397(10280):1177-1178
pubmed: 33713595
Tumori. 2021 Oct;107(5):446-451
pubmed: 33176598
Lancet. 2020 Sep 12;396(10253):e27-e28
pubmed: 32891216
Environ Res. 2022 Mar;204(Pt C):112342
pubmed: 34748775
Eur J Cancer. 2021 May;148:112-116
pubmed: 33743478
PLoS One. 2020 Oct 30;15(10):e0240649
pubmed: 33125393
J Glob Health. 2020 Jun;10(1):010335
pubmed: 32257150
JAMA. 2021 Feb 9;325(6):529-531
pubmed: 33404586
Pathogens. 2021 May 21;10(6):
pubmed: 34064143
BMJ. 2020 Feb 28;368:bmj.m799
pubmed: 32111645